REDUCED MORTALITY RATES WITH ANTI-TUMOR NECROSIS FACTOR ALPHA DIRECTED THERAPY WHEN COMPARED TO PROLONGED CORTICOSTEROID THERAPY FOR INFLAMMATORY BOWEL DISEASE

被引：2
|
作者：
Lewis, James D.
Scott, Frank I.
Brensinger, Colleen M.
Roy, Jason A.
Osterman, Mark T.
Mamtani, Ronac
Chen, Lang
Yun, Huifeng
Xie, Fenglong
Curtis, Jeffrey R.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)30570-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
247
引用
收藏
页码：S64 / S65
页数：2
相关论文
共 50 条
  • [31] Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease Reply
    Bouguen, Guillaume
    Brunet, Tanguy
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (04) : 855 - 856
  • [32] Malignancy Outcomes in Inflammatory Bowel Disease Patients on Immune Modulators and Anti-Tumor Necrosis Factor Therapy
    Patel, Umangi
    Lichtenstein, Gary
    Scott, Frank
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S484 - S484
  • [33] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Alexis Calloway
    Robin Dalal
    Dawn B. Beaulieu
    Caroline Duley
    Kimberly Annis
    Lawrence Gaines
    Chris Slaughter
    David A. Schwartz
    Sara Horst
    Digestive Diseases and Sciences, 2017, 62 : 3563 - 3567
  • [34] Influence of anti-tumor necrosis factor-alpha therapy on pregnant women with inflammatory bowel disease and their children's immunity
    Lee, Ko Eun
    Jung, Sung-Ae
    Park, Sang Hyoung
    Moon, Chang Mo
    Shim, So Yeon
    Kim, Eun Soo
    Cho, Su Jin
    Kim, Seong-Eun
    Cho, Kwang Bum
    Yang, Suk-Kyun
    INTESTINAL RESEARCH, 2019, 17 (02) : 237 - 243
  • [35] Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease
    Nawaz, Ahmad
    Glick, Laura R.
    Chaar, Abdelkader
    Li, Darrick K.
    Gaidos, Jill K. J.
    Proctor, Deborah D.
    Al-Bawardy, Badr
    ANNALS OF GASTROENTEROLOGY, 2023, 36 (01): : 39 - +
  • [36] Ten-year outcomes of anti-tumor necrosis factor therapy in inpatients with inflammatory bowel disease
    Tai, J. E.
    Pavli, P.
    Subramaniam, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 148 - 148
  • [37] Healing of Apical Periodontitis in Patients with Inflammatory Bowel Diseases and under Anti-tumor Necrosis Factor Alpha Therapy
    Cotti, Elisabetta
    Mezzena, Silvia
    Schirru, Elia
    Ottonello, Olimpia
    Mura, Michela
    Ideo, Francesca
    Susnik, Marta
    Usai, Paolo
    JOURNAL OF ENDODONTICS, 2018, 44 (12) : 1777 - 1782
  • [38] Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
    Pagnini, Cristiano
    Pizarro, Theresa T.
    Cominelli, Fabio
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [39] Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease
    Cottone, Mario
    Kohn, Anna
    Daperno, Marco
    Armuzzi, Alessandro
    Guidi, Luisa
    D'Inca, Renata
    Bossa, Fabrizio
    Angelucci, Erika
    Biancone, Livia
    Gionchetti, Paolo
    Ardizzone, Sandro
    Papi, Claudio
    Fries, Walter
    Danese, Silvio
    Riegler, Gabriele
    Cappello, Maria
    Castiglione, Fabiana
    Annese, Vito
    Orlando, Ambrogio
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (01) : 30 - 35
  • [40] How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?
    Ward, Mark G.
    Irving, Peter M.
    Sparrow, Miles P.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (40) : 11331 - 11342
12345